We are live on
!
Find out more
AFA
Abacus FCF Advisors Portfolio holdings
AUM
$444M
1-Year Est. Return
44.44%
This Fund
S&P 500
This Quarter
Est. Return
+14.38%
1 Year Est. Return
+44.44%
3 Year Est. Return
+142.32%
5 Year Est. Return
+208.76%
10 Year Est. Return
–
AUM
$344M
AUM Growth
+$156M
(+83%)
Cap. Flow
+$125M
Cap. Flow
% of AUM
36.16%
Top 10 Holdings %
Top 10 Hldgs %
27.56%
Holding
198
New
56
Increased
84
Reduced
5
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$11.6M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$5.79M |
| 3 |
AbbVie
ABBV
|
+$5.04M |
| 4 |
UnitedHealth
UNH
|
+$4.1M |
| 5 |
Visa
V
|
+$3.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.29M |
| 2 |
Eli Lilly
LLY
|
+$2.18M |
| 3 |
ExxonMobil
XOM
|
+$2.06M |
| 4 |
Chevron
CVX
|
+$1.92M |
| 5 |
Coca-Cola
KO
|
+$1.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.76% |
| 2 | Healthcare | 14.57% |
| 3 | Consumer Discretionary | 10.66% |
| 4 | Industrials | 8.44% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
176
Marsh
MRSH
$94.3B
| – | – |
-6,431
| Closed | -$1.22M |
|
177
MSCI
MSCI
$42.4B
| – | – |
-1,093
| Closed | -$561K |
|
|
178
Microsoft
MSFT
$2.9T
| – | – |
-16,748
| Closed | -$5.29M |
|
179
Mettler-Toledo International
MTD
$28.1B
| – | – |
-416
| Closed | -$461K |
|
180
MaxLinear
MXL
$5.19B
| – | – |
-8,385
| Closed | -$187K |
|
181
ONE Gas
OGS
$5.01B
| – | – |
-12,884
| Closed | -$880K |
|
182
Option Care Health
OPCH
$3.58B
| – | – |
-4,370
| Closed | -$141K |
|
183
O'Reilly Automotive
ORLY
$75.1B
| – | – |
-24,420
| Closed | -$1.48M |
|
184
Otis Worldwide
OTIS
$27.9B
| – | – |
-9,036
| Closed | -$726K |
|
185
PBF Energy
PBF
$7.49B
| – | – |
-13,356
| Closed | -$715K |
|
186
Procter & Gamble
PG
$340B
| – | – |
-8,014
| Closed | -$1.17M |
|
187
Philip Morris
PM
$309B
| – | – |
-16,351
| Closed | -$1.51M |
|
188
Progress Software
PRGS
$1.75B
| – | – |
-13,136
| Closed | -$691K |
|
189
Regeneron Pharmaceuticals
REGN
$72.9B
| – | – |
-1,083
| Closed | -$891K |
|
190
RLI Corp
RLI
$6.02B
| – | – |
-8,214
| Closed | -$558K |
|
191
Sylvamo
SLVM
$1.52B
| – | – |
-1,083
| Closed | -$47.6K |
|
192
Synopsys
SNPS
$71.6B
| – | – |
-3,222
| Closed | -$1.48M |
|
193
Ulta Beauty
ULTA
$21.8B
| – | – |
-2,905
| Closed | -$1.16M |
|
194
United Parcel Service
UPS
$88.9B
| – | – |
-247
| Closed | -$38.5K |
|
195
Veeva Systems
VEEV
$33.8B
| – | – |
-2,982
| Closed | -$607K |
|
196
VeriSign
VRSN
$26.3B
| – | – |
-3,943
| Closed | -$799K |
|
197
Walmart Inc
WMT
$909B
| – | – |
-18,585
| Closed | -$991K |
|
|
VMW
198
DELISTED
VMware, Inc
VMW
| – | – |
-4,760
| Closed | -$792K |
|
Similar funds
SGCM
WCP
ACA
JDLA
FWSM
MLIC
BI
TC
Abacus FCF Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Abacus FCF Advisors held 198 positions worth $344M, up 83% from $188M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Abacus FCF Advisors deployed $125M of net new capital in Q4 2023, opening 56 new positions and adding to 84 existing holdings. Its largest new stake was Meta Platforms (Facebook): 11,598 shares worth $4.11M.
By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 37% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was ExxonMobil, an estimated $2.06M trimmed.
- Abacus FCF Advisors's largest Q4 2023 buy was Meta Platforms (Facebook): 11,598 shares worth $4.11M.
- Abacus FCF Advisors added most to Apple in Q4 2023, an estimated $11.6M increase.
- Abacus FCF Advisors's biggest Q4 2023 reduction was ExxonMobil, cutting an estimated $2.06M.
- Abacus FCF Advisors fully exited Microsoft in Q4 2023, selling an estimated $5.29M.
- Abacus FCF Advisors's ten largest holdings make up 28% of its $344M portfolio in Q4 2023.
- Abacus FCF Advisors opened 56 new positions and closed 53 in Q4 2023.
- Abacus FCF Advisors's portfolio value rose 83% quarter-over-quarter to $344M.
Based on Abacus FCF Advisors's 13F filing for Q4 2023, filed 4 Jan 2024.